
Baxter International Inc BAX.N reported quarterly adjusted earnings of 58 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 88 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 52 cents per share. Wall Street expected results to range from 51 cents to 53 cents per share.
Revenue fell 29.1% to $2.75 billion from a year ago; analysts expected $2.67 billion.
Baxter International Inc's reported EPS for the quarter was a loss of $1.00.
The company reported a quarterly loss of $512 million.
Baxter International Inc shares had risen by 5.7% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.2% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 12 "hold" and 2 "sell" or "strong sell."
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Baxter International Inc is $38.00
This summary was machine generated from LSEG data February 20 at 02:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2024 | 0.52 | 0.58 | Beat |
Sep. 30 2024 | 0.78 | 0.80 | Beat |
Jun. 30 2024 | 0.66 | 0.68 | Beat |
Mar. 31 2024 | 0.61 | 0.65 | Beat |